Meeting
2024 ASCO Gastrointestinal Cancers Symposium
One of these is not like the others: A descriptive study of the attenuated phenotype of PMS2.
Authors
Edward D. Esplin
Invitae, San Francisco, CA
Edward D. Esplin , Brandie Heald , Sarah M. Nielsen , Rachel Ellsworth , Emily M. Russell , Daniel Esteban Pineda Alvarez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 76)
DOI
10.1200/JCO.2024.42.3_suppl.76
Abstract #
76
Poster Bd #
E19
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.
First Author: Alicia Latham
Poster
2023 ASCO Annual Meeting
Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients.
First Author: Kara K. Landry
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic variants among Mexican patients with colorectal cancer referred for genetic cancer risk assessment.
First Author: Jose Luis Rodriguez Olivares
Poster
2021 Gastrointestinal Cancers Symposium
The clinical and molecular characteristics of patients with personal history of colorectal cancer evaluated by cancer genetics counseling services.
First Author: Veena Krishnan